Abstract:Introduction: Leptin is a metabolic peptide hormone produced by adipocytes, with proven roles in proliferation of prostate cancer cells and of prostate cells in animal models of benign prostatic hyperplasia (BPH). Thus, the role of leptin as a molecular link connecting BPH and lower urinary tract symptoms (LUTS) suggestive of BPH with metabolic symptoms appears feasible but is still unknown. In fact, a connection between metabolic syndrome and BPH is becoming increasingly evident from epidemiologic studies. Key factors of Lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH/LUTS) are increased prostate smooth muscle tone, and prostate enlargement. Here, we examined the effects of leptin on contraction of human prostate smooth muscle and on growth of stromal cells. Methods: We performed microarray analysis to identify genes (fold change ≥ 1.5) associated with BPH/LUTS progression, such as those involved in proliferation, apoptosis, and mitochondrial metabolism, in rat prostate tissue (data from GSE129561). We then used electric field stimulation (EFS) to induce frequency-dependent, neurogenic contractions of human prostate strips, which were enhanced by leptin. We also examined the effect of leptin on human prostate stromal cells (WPMY-1) and found increased cell proliferation and viability upon exposure. To explore the underlying mechanism, we conducted mitochondrial stress assay using near-infrared (NIR) fluorescent dye and flow cytometry (FACS) analysis and observed reduced cellular apoptosis and preserved mitochondrial membrane potential (∆ψM) after leptin treatment. Results: Microarray analysis reveals that leptin regulates prostate smooth muscle contraction and stromal cell proliferation, shedding new light on its involvement in BPH/LUTS pathogenesis and mitochondrial function. We found that leptin enhanced the proliferation rate of prostate stromal cells relative to the control group (0.67 ± 0.05 vs 0.54 ± 0.08, p-value= 0.024). Moreover, leptin (100 ng/mL) potentiated the frequency-dependent, neurogenic contractions of prostate strips elicited by EFS (p= 0.047 between leptin and control group). We also show that leptin treatment increased the mitochondrial membrane potential of prostate stromal cells and inhibited mitochondrial apoptosis. Discussion: Our results indicate that leptin stimulates the contractility and proliferation of smooth muscle and stromal cells in the human prostate, implying a potential role for leptin in exacerbating BPH/LUTS in obese men. Leptin modulation may be a beneficial therapeutic strategy for patients with metabolic syndrome and BPH/LUTS. Further studies are warranted to elucidate the mechanisms and implications of the leptin system in BPH/LUTS.

Lack of Adiponectin and Adiponectin Receptor 1 Contributes to Benign Prostatic Hyperplasia

Adiponectin Deficiency Contributes to the Development and Progression of Benign Prostatic Hyperplasia in Obesity.

Clinical Significance Of Single Nucleotide Polymorphisms Of Adiponectin Gene In Chinese Benign Prostatic Hyperplasia Patients

Role of Adiponectin in Prostate Cancer: A Preliminary Study

Research progresses on the role of adiponectin and its receptors in prostate cancer

Adiponectin-Induced Antitumor Activity on Prostatic Cancers Through Inhibiting Proliferation

Body Size and Serum Levels of Insulin and Leptin in Relation to the Risk of Benign Prostatic Hyperplasia.

Effects of Inflammatory Responses, Apoptosis, and STAT3/NF-κB- and Nrf2-mediated Oxidative Stress on Benign Prostatic Hyperplasia Induced by a High-Fat Diet

Untargeted metabolomics reveals that declined PE and PC in obesity may be associated with prostate hyperplasia

Adiponectin As A Potential Tumor Suppressor Inhibiting Epithelial-To-Mesenchymal Transition but Frequently Silenced in Prostate Cancer by Promoter Methylation

High glucose promotes benign prostatic hyperplasia by downregulating PDK4 expression

The Role of Adiponectin in Breast Cancer: A Meta-Analysis

Identification Of Key Genes And Pathways In Benign Prostatic Hyperplasia

Adiponectin Inhibits VEGF-A in Prostate Cancer Cells

Body mass index and risk of BPH: a meta-analysis

Role of P-Erk1/2 in Benign Prostatic Hyperplasia During Hyperinsulinemia.

Circulating Levels of Blood Biomarkers and Risk of Benign Prostatic Hyperplasia: Results from Two Large Cohorts in Europe and East Asia

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia

Leptin Mediates Prostate Stromal Cell Proliferation, Smooth Muscle Contraction, and Mitochondrial Function in Benign Prostate Hyperplasia

Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland

A Preliminary Study of the Impact of Insulin Resistance on the Growth of the Prostate in Patients with Benign Prostatic Hyperplasia